Re: Breast cancer screening error: fatal mistake or lucky escape?

Source: BMJ Comments - Category: General Medicine Source Type: forums

Related Links:

MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer, Published online: 20 February 2019; doi:10.1038/s41416-019-0395-8MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Abstract Anterior gradient protein 2 homolog (AGR) is a potential tumor biomarker and plays an important role in tissue development and regeneration. The intracellular detection of AGR is rarely reported. By conjugating the AGR aptamer with a cytosine base sequence as Ag cluster template, a highly fluorescent probe (MA@AgNCs) was synthesized for targeting intracellular AGR. The MA@AgNCs display a maximum fluorescence peak at 565 nm, and possess an excellent quantum yield (QY = 87.43%), small size, great biocompatibility, low toxicity, and good stability. Moreover, the as synthesized MA@AgNCs show high specific...
Source: Talanta - Category: Chemistry Authors: Tags: Talanta Source Type: research
Juanying Xie, Ran Liu, Joseph Luttrell, Chaoyang Zhang
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
Women want to receive results from their screening mammograms quickly, according...Read more on AuntMinnie.comRelated Reading: Women unaware of importance of baseline mammography Mammo recalls don't keep women from other tests Women want to know their breast cancer risk
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Publication date: Available online 19 February 2019Source: Journal of Bone OncologyAuthor(s): C. Wilson, C. Martin, M.C. WinterAbstractBackgroundAdjuvant bisphosphonates (BPs) are recommended as part of routine early breast cancer treatment for many postmenopausal (PM) women within the past year. There is a paucity of ‘real world’ data on compliance and patient satisfaction with oral BPs in this population. The aim of our study was to investigate patient reported compliance and toxicity of these drugs in a retrospective cohort study.Patients and methods413 patient were identified as receiving adjuvant oral BPs ...
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
Incremental cost - effectiveness ratio varies across clinical risk groups, sensitive to patient age
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Research, Preventive Medicine, News, Source Type: news
Condition:   Breast Cancer Intervention:   Drug: Imaging Drug FluorThanatrace (FTT) Sponsor:   University of Pennsylvania Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
In this study, to achieve the combined photothermal-chemotherapy of breast cancer, a pH-sensitive oxidized hyaluronic acid-decorated dihydroxyphenyl/hydrazide bifunctionalized hydroxyethyl chitosan (DHHC)-gold nanorod (GNR) conjugate was developed. DHHC was synthesized by successive dihydroxyphenylation and hydrazidation of hydroxyethyl chitosan through carbodiimide reaction and click chemistry, respectively. The conjugate was obtained by chemically bonding DHHC onto GNR via Au-catechol bonds. Doxorubicin (DOX) was loaded onto the conjugate via an acid-labile hydrazone linkage with a drug loading content of 5.1%. DOX-loade...
Source: Carbohydrate Polymers - Category: Biomedical Science Source Type: research
Publication date: Available online 19 February 2019Source: European Journal of Surgical OncologyAuthor(s): Kang Wang, Yang Shi, Zhu-Yue Li, Ye-Lei Xiao, Jie Li, Xiang Zhang, Hong-Yuan LiAbstractIntroductionRole of surgery in the management of de novo stage IV breast cancer (BC) remains controversial. We aimed to determine the survival benefit of primary surgery on the basis of metastatic pattern.Materials and methodsA retrospective cohort study based on the SEER database was conducted to identify patients with de novo stage IV BC diagnosed between 2010 and 2015. Patients were divided into surgery and non-surgery group, and...
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | General Medicine